TrialClinical pharmacokinetics2024

Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial.

Sarah Louise Dombernowsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.